Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bioluteina
- Development stage
- Unknown
- Lead developer
- Lek-AM
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Bioluteina is a branded multi-ingredient dietary supplement marketed for eye health and vision support, typically combining the carotenoid lutein with other nutrients such as omega-3 fatty acids from fish oil and additional carotenoids and vitamins. It is positioned to help protect the retina and macula by providing macular pigments and antioxidant support, leveraging lutein’s ability to filter blue light and quench reactive oxygen species, while omega‑3 fatty acids and co-formulated micronutrients support retinal cell membrane integrity and general ocular health.[1][5][6]
- Brand names
- BioluteinaBioluteina TotalBioluteină plus
02
Targets
IGF-1R (Insulin-like growth factor 1 receptor)
Beyond the preview
Go deeper on Bioluteina.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioluteina.